• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
TBD - Tel Aviv University
TBD - Tel Aviv University

... I.V Drug Immediately ...
Drug interactions
Drug interactions

... The risk of drug interactions increases with the number of drugs used. The rate of ADR in patients taking 6–10 drugs was 7%, rising to 40% in those taking 16–20 drugs, with the exponential rise being largely attributable to drug interactions. In a high-risk group of emergency department patients, th ...
Part B Coverage
Part B Coverage

... » Watch evolution of Part D formularies and prior authorizations  This is an issue that will continue to be “ironed out” over the next few years ...
DRUG INTERACTIONS
DRUG INTERACTIONS

... They may also result from inhibition of metabolism of a drug with epileptogenic properties. For instance, when erythromycin is prescribed for someone receiving clozapine, the antibiotic inhibits CYP3A4, thereby decreasing the metabolism and increasing the plasma concentration of the antipsychotic. T ...
19 Common pharmacology
19 Common pharmacology

... N-oxypropranolol ...
Organ Blood Flow
Organ Blood Flow

... Comment:the patient’s ataxia has resulted from an increases in the free concentration of phenytoin. The clinical relevance of plasma protein binding is often much less clear cut than in this example. ...
Prescribing in the Elderly - Benton Franklin County Medical Society
Prescribing in the Elderly - Benton Franklin County Medical Society

... “Age nearing or surpassing the average life span” ...
Choose the correct answer for questions (1-90: Question 1
Choose the correct answer for questions (1-90: Question 1

... 28. All of these statements about paracetamol is true except: a. Category B drugs, so it is safe during pregnancy b. 150 mg strength is used for infants c. Hepatitis is the main complication from paracetamol overdose d. Has anti-inflammatory effect e. Acetylcysteine is the antidote for paracetamol ...
Slide 1
Slide 1

... A drug is a natural or synthetic substance designed to affect the subject psychologically or physiologically. “Controlled substances” are drugs that are restricted by law. The Controlled Substances Act is a law that was enacted in 1970; it lists illegal drugs, their categories, and penalties for pos ...
Chapter 7 PPT
Chapter 7 PPT

... A drug is a natural or synthetic substance designed to affect the subject psychologically or physiologically. “Controlled substances” are drugs that are restricted by law. The Controlled Substances Act is a law that was enacted in 1970; it lists illegal drugs, their categories, and penalties for pos ...
Slide 1 - edl.io
Slide 1 - edl.io

... A drug is a natural or synthetic substance designed to affect the subject psychologically or physiologically. “Controlled substances” are drugs that are restricted by law. The Controlled Substances Act is a law that was enacted in 1970; it lists illegal drugs, their categories, and penalties for pos ...
Drug Myths and Facts
Drug Myths and Facts

... Myth: As soon as a person feels normal, all the drug is out of the body. Fact: Long after the effects of the drug stop being felt, the drug can still be in the body. For example, cocaine can be found in the body up to one week and marijuana up to 3 months after a single use. ...
Investigational Drugs
Investigational Drugs

... disease (affecting fewer than 200,000 people in US) or one that will not generate enough revenue to justify the costs of research and development. ...
министерство здравоохранения российской федерации
министерство здравоохранения российской федерации

... drug has antiviral and immunomodulating effect, it activates antiviral, antimycotic and antimicrobial immunity. It make antiviral effect against various RNA- and DNAcontaining viruses. The drug clinical use has proved its high efficacy, high tolerance level, no toxicity (IC50>4000mkg/ml) and no unwa ...
Article 07-10: Carcinogenicity of Lipid-lowering Drugs
Article 07-10: Carcinogenicity of Lipid-lowering Drugs

... “Unfortunately, the subsequent popularity of gemfibrozil suggests that its use has not been restricted to this small group.” “For patients not at high short-term risk of CHD death, especially patients with life expectancies of more than 10 to 20 years, pharmacologic treatment probably should be avoi ...
TEXT: Basic and Clinical Pharmacology by
TEXT: Basic and Clinical Pharmacology by

... Students are responsible for all notes, tests and assignments. No make up quizzes will be allowed. Unexcused absence from a test will mean an automatic zero. Excuses due to illness should preferably be made before the test begins and no later than the next meeting of class. Five points will be dedu ...
atorvastatin + amlodipine
atorvastatin + amlodipine

... patient’s blood pressure levels. Doses of treatments for hypercholesterolaemia are based on cholesterol levels. A fixeddose combination product is hardly ideal when the dose of the antihypertensive drug has to be adjusted in a patient whose cholesterol level is properly controlled, or when the dose ...
(lec 8) adverse d..
(lec 8) adverse d..

... By. Dr. Abdul Latif Mahesar Dept. of Medical Pharmacology King Saud University ...
Supplemental Indications
Supplemental Indications

... Pricing models in European countries have been evolving in a value-based direction for some years, but the process is never simple. Factors taken into account may include a drug’s effect on the duration of a disease, survival rates, side-effect profile, quality of life improvement, and size of the p ...
drug use and abuse - North Allegheny School District
drug use and abuse - North Allegheny School District

... The first step in the recovery process is detoxification – the removal of the drug from the body, usually under medical supervision This step also includes restoring one’s mental health Most experts recommend total abstinence Relapse – slips from recovery, or periodic returns to use can happen ...
Biological therapies: how can we afford them?
Biological therapies: how can we afford them?

... Christopher Kelly and Fraz Mir examine why they are so expensive and what can be done to increase access ...
Prior Authorization Form
Prior Authorization Form

... Reason for discontinuation of the drug ...
najważniejsze izoenzymy cytochromu p450 biorace udział w
najważniejsze izoenzymy cytochromu p450 biorace udział w

... Chair Of Pharmacology, Dept. Of Clinical Pharmacology Jagiellonian University College of Medicine Krakow ...
Investigational New Drug (IND)
Investigational New Drug (IND)

... satisfied that the drug was safe – NOT just the manufacturer – prior to distribution ...
NewsletterVol 3 (#4) - About Outcome Resources
NewsletterVol 3 (#4) - About Outcome Resources

... Studies in patients with cancer and AIDS have shown Megace to be an effective appetite stimulant that is associated with weight gain. Alternatively, studies in geriatric patients including mostly nursing home residents have failed to demonstrate similar consistent benefits. Reports on the clinical s ...
< 1 ... 132 133 134 135 136 137 138 139 140 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report